Cargando…
Oxaliplatin related lncRNAs prognostic models predict the prognosis of patients given oxaliplatin-based chemotherapy
BACKGROUND: Oxaliplatin-based chemotherapy is the first-line treatment for colorectal cancer (CRC). Long noncoding RNAs (lncRNAs) have been implicated in chemotherapy sensitivity. This study aimed to identify lncRNAs related to oxaliplatin sensitivity and predict the prognosis of CRC patients underw...
Autores principales: | Zhou, Qing-nan, Lei, Rong-e, Liang, Yun-xiao, Li, Si-qi, Guo, Xian-wen, Hu, Bang-li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223895/ https://www.ncbi.nlm.nih.gov/pubmed/37245016 http://dx.doi.org/10.1186/s12935-023-02945-3 |
Ejemplares similares
-
The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis
por: Sun, Fangfang, et al.
Publicado: (2019) -
Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
por: Li, Chong, et al.
Publicado: (2023) -
LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023) -
The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
por: Yang, Li-Rong, et al.
Publicado: (2022) -
Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: Chen, Fei, et al.
Publicado: (2022)